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Abstract 
 
Matrix assisted laser desorption ionization (MALDI) imaging mass spectrometry (IMS) is 
largely performed on fresh frozen tissue whereas clinical tissue samples stored long term are fixed 
in formalin, and the fixation process is thought to cause signal suppression for lipid molecules. 
Studies have shown that fresh frozen brain tissue sections washed with ammonium formate (AF) 
prior to matrix application in the MALDI-IMS procedure display an increase in signal intensity 
and sensitivity for lipid molecules while maintaining molecular spatial distribution throughout the 
tissue. Work in this thesis compares MALDI data of ganglioside molecules from fresh frozen and 
post-fixed rat brain samples, and post-fixed human brain samples washed with AF.  Results 
demonstrate that MALDI-IMS spectra for gangliosides are significantly enhanced in fresh frozen 
rat brain, formalin-fixed rat brain and formalin fixed human brain samples washed with AF. This 
method will allow for the analysis of gangliosides from formalin-fixed clinical samples, which can 
open additional avenues for neurodegenerative disease research. 
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Summary for Lay Audience 
 
Matrix assisted laser desorption ionization (MALDI) imaging mass spectrometry (IMS) is 
used to analyze molecules directly on tissue samples providing information about molecules 
present in the samples and where they are located. Tissue samples are often stored frozen or in a 
chemical solution called formalin, currently frozen tissue is largely used for MALDI as the 
chemical storage is thought to interfere with some types of molecules within tissue samples, such 
as lipid molecules.  Some studies have demonstrated that molecules in frozen tissue can be better 
detected if the tissue is washed with ammonium formate (AF) before MALDI is performed, this 
method not only improves detection but also retains the location of molecules within the samples. 
This work aims to see if gangliosides, a lipid found in the brain, in human tissue stored in formalin 
can be analysed in MALDI imaging by comparing results from frozen and formalin rat brains and 
human brain samples washed with AF.  Results show that MALDI data for gangliosides was 
improved in all types of tissue tested through the use of an AF wash.  Images generated from 
MALDI were shown with molecule location retained after tissue washing.  These results show that 
this method will allow for gangliosides to be analysed in samples stored in formalin in a clinical 
setting which can offer new research opportunities with neurodegenerative diseases. 
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Chapter 1: Introduction 
 
1.1 Mass Spectrometry 
 
Mass spectrometry (MS) is a versatile analytical technique that separates ions based on their 
mass to charge ratio (m/z). MS is able to analyze samples as solids, liquids and gases by converting 
sample molecules to ions from both simple and complex mixtures.  It can be used to determine the 
masses and chemical identity or structure of analyte molecules and chemical compounds. Samples 
are generally broken apart or fragmented into ions, but can be ionized with minimal fragmentation, 
and separated by m/z ratio which can be determined by subjecting them to a magnetic field. Results 
of MS are presented as a plot of sample intensity as a function of m/z, called a mass spectrum. A 
mass spectrometer consists of three main components; an ion source, which converts analyte 
molecules into ions, a mass analyzer that separates ions based on the masses and a detector, which 
measures the abundance of ions at each m/z (1).  
Several ionization techniques exist for various samples types and desired outcomes.   These 
techniques can be divided into two broad categories, ‘hard’ ionization techniques wherein large 
amounts of residual energy are transferred to analyte molecules causing a high degree of 
fragmentation and ‘soft’ ionization techniques where a small amount of residual energy is 
transferred resulting in little to no fragmentation of analyte molecules.  Hard ionization is useful 
for the detailed mass spectrum that a greater degree of fragmentation provides. When analyzed 
these mass spectra give important structural and characteristic information about molecules and 
compounds present in analyte samples. The most common example of a hard ionization technique 
is electron ionization, also known as Electron Impact Ionization, which involves the interaction of 
energetic electrons with analyte molecules to cause ionization (1,2). Soft ionization is useful for 
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analytes containing a larger number of different molecules.  Since there is little fragmentation, 
each molecule will appear in the mass spectrum at respective m/z ratios giving information on 
relative abundance of compounds present in a sample.  It is possible to obtain further structural 
information for specific molecules by selecting them after they have passed through the mass 
analyzer, fragmenting the selected molecule(s) and accelerating the fragments through a second 
mass analyzer resulting in a mass spectrum that can be analyzed to determine structural 
characteristics of the molecule, this is known as tandem mass spectrometry (MS/MS).  Common 
examples of soft ionization techniques include Electrospray Ionization (ESI) which involves using 
an aerosol created by applying a high voltage to a liquid (1,3) and Matrix Assisted Laser 
Desorption Ionization (MALDI) which will be explained in detail in the next section.  Once 
ionized, molecules are transported to the mass analyzer via magnetic or electric fields. 
Mass analyzers act to separate ions based on m/z ratio have several important characteristics 
including mass accuracy, how close the detected m/z is to the actual m/z of the analyte molecule, 
mass resolving power, the ability to distinguish between two peaks in a mass spectrum that are 
close in mass, and mass range, the range of masses a given analyzer is able to analyze.  Typical 
mass analyzers include quadrupole mass analyzers that use oscillating electric fields to selectively 
stabilize and destabilize ions passing through 4 parallel rods generating a radio frequency 
quadrupole field allowing only selected ions to pass through at a given time (4) and time-of-flight 
(TOF) mass analyzers that accelerate ions through a constant potential separating molecules based 
on the time it takes for each to reach the detector (5).  Ion traps are also used as mass analyzers 
such as the quadrupole ion trap which operates on the same principles as quadrupole mass 
analyzers but ions are trapped and selectively ejected and orbitraps that electrostatically trap ions 
in orbit around a central electrode causing oscillation and generating images whose frequencies 
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can determine m/z (6). The detector then records the charge or current of the separated ions 
measured as they contact or pass by a surface.  
1.2 History of MALDI IMS 
 
MALDI Imaging Mass Spectrometry (IMS) is at the forefront of molecular imaging 
approaches for the spatial visualization of molecules in biological samples and is used to detect 
and localize proteins (7, 8), peptides (9), lipids (10) and metabolites (11).  MALDI is a MS 
ionization technique that utilizes an energy absorbing matrix, which is then ablated with a laser to 
create ions from a wide range of molecules.  This method can be used to analyze molecules in a 
mixture with the matrix, as well as analyzing molecules directly from sectioned tissue samples 
mounted onto semi conductive indium tin oxide (ITO) slides. MALDI has been used to analyze 
many different types of biomolecules, such as proteins, peptides and lipids, as well as large organic 
molecules that tend to fragment during the ionization process.  
The term MALDI was first coined by Franz Hillenkamp and Michael Karas in 1985.  They 
discovered that alanine, an amino acid, was ionized more effectively when it was mixed with 
another amino acid, tryptophan. In this instance the tryptophan was acting as a ‘matrix’, absorbing 
the energy of the laser and assisting with the ionization of alanine.  In 1987, Koichi Tanaka and 
his colleagues used a method they termed ‘ultra fine metal plus liquid matrix method’ to ionize 
and detect biomolecules exceeding 30,000 Daltons in size.  This method utilized a matrix 
consisting of 30 nm cobalt particles in glycerol with a 337 nm nitrogen laser as the ionization 
source and is considered a breakthrough point for large molecule imaging in MALDI.  Tanaka was 
later awarded one quarter of the Nobel Prize for Chemistry in 2002 for demonstrating that, with 
proper combination of laser intensity and matrix composition, large molecules such as proteins 
can be ionized (12).  Soon after, Karas and Hillenkamp were able to ionize proteins exceeding 65 
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kD in size utilizing a 266 nm laser and a nicotinic acid matrix (13). In the 1990s, relatively 
inexpensive 337 nm nitrogen lasers became available bringing with it the introduction of 
commercial MALDI instruments giving an increasing number of researchers access to MALDI 
instruments (14). 
MALDI is one of several MS ionization techniques that are capable of analyzing molecules 
directly from intact tissue sections and is capable of generating images containing MS data, hence 
the term IMS (15,16).  IMS is a technique that acquires region specific molecular data from intact 
biological tissue samples (17-21).  Mass spectrometers provide a unique form of imaging utilizing 
high sensitivity and molecular specificity to generate images that visually represent the molecular 
biology of the specimen being analyzed.  Important in IMS, is the preservation of spatial integrity 
of the sample being analyzed, requiring data acquisition and sample preparation protocols to differ 
from other mass spectrometric techniques, such as secondary ion mass spectrometry (SIMS) (22) 
and Desorption Electrospray Ionization (DESI) (23). 
The general process of the MALDI IMS protocol requires the tissue sample to first be sectioned 
and mounted on a conductive slide. The matrix is then applied to the tissue section which extracts 
analytes and aids in the desorption/ionization of analyte molecules during laser ablation.  Direct 
analysis of the sample is then performed by laser ablation in a raster or grid pattern, resulting in 
the generation of a mass spectrum for each point the laser ablated. With the cumulative data 
obtained from laser ablation, an image is formed where each pixel contains MS data and is 
visualized as an intensity map that can be adjusted to focus on different molecules within the mass 
range scanned.  The distance between each point of laser ablation determines the spatial resolution 
of the image obtained. In other words, the closer together each point of ablation is, the smaller the 
pixel size within the generated image and the higher the spatial resolution.  MALDI data is 
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generally acquired in the range of 50 and 200 µm but some instruments are capable of imaging 
with a resolution less than 1 µm (24). 
 MALDI has various advantages that make it ideal for the imaging of biological samples. 
As previously mentioned, MALDI is a ‘soft ionization’ technique allowing for analysis of 
molecules in a wide range of sizes from hundreds of daltons to 100 kDa and the spectra generated 
through MALDI are often composed of singly charged ions allowing for easier analysis of larger 
molecules such as proteins (25).  MALDI is also capable of focusing on very specific regions of 
tissue samples due to the use of a laser as the ionization source, which can be directed to 
histologically unique regions instead of imaging an entire tissue section.   
 There are two common methods of obtaining region specific information from tissue 
samples in MALDI. The first, used in the work depicted in this thesis, is to image the entire section 
of tissue and obtain intensity maps of the molecules of interest, which can be represented in a false 
color display.  Matrix is applied uniformly over the tissue section and a complete data set of many 
hundreds or thousands of m/z values is obtained in data acquisition.  The second method is to 
obtain data from small selected areas of a tissue sample with region selection directed often 
through microscopy or other imaging techniques, termed histology directed molecular imaging 
(26).  This technique requires that matrix only be applied to selected areas, thus requiring less mass 
spectra to be obtained, reducing file size and acquisition time by not imaging entire sections and 
selected areas can be visualized by superimposing the MALDI image with another image obtained 
from the technique used to initially select the region. Both approaches are utilized based on the 
desired outcomes of the experiment performed. For example, whole section imaging is used to 
assess the distribution of molecules within the tissue and the histology directed method can be 
used to assess selected regions with specific cell types or morphological differences, often assisted 
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by a pathologist or biologist. The histology directed approach has been applied to both fresh frozen 
and formalin fixed tissue samples (26-35), however imaging of entire sections has yet to be 
explored in formalin fixed tissue to our knowledge. Both methods of tissue preservation each have 
their respective strengths and weaknesses which will be explored in a later section.  
1.3 MALDI IMS Workflow 
 
Sample preparation, including tissue storage, sectioning, matrix selection, and method of 
matrix deposition all play a critical role in determining the quality of MALDI IMS data (34). The 
first step in preparation of stored tissue samples for MALDI analysis is the sectioning of tissue.  
Although a straightforward process, utilizing a cryomicrotome to obtain thin sections desired for 
MALDI analysis, there are special considerations that must be taken for MALDI samples.  Often 
tissue is stored in embedding media such as optimal cutting temperature (OCT) compound, a 
polymer that aids in positioning samples for sectioning and is useful for histological sectioning.  
This polymer causes ion suppression, impacting the number of ions detected in MALDI analysis 
(37,38).  To overcome this issue, our lab freezes specimens directly to the cryotome chuck using 
water.  Ionization efficiency, referring to the number of generated ions per molecules consumed, 
is dependent on the thickness of sections analyzed (39).  It is recommended to use thinner tissue 
sections (2-5µm) for molecules of higher molecular weight, such as proteins and thicker sections 
(5-20µm) for lower molecular weight analytes (40). 
Tissue sections can then be thaw mounted to a solid surface by inverting a warm slide overtop 
of the tissue section, allowing the section to adhere to the surface or place sections on a slide of 
equal temperature to the section and warming from the underside to mount the section.  Slides are 
often conductive to support application of the potential required to accelerate ions in the mass 
spectrometer source.  For these purposes, ITO slides are often used as it provides the electrical 
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conductance preferred and allows for subsequent microscopic analysis or staining of tissue 
sections if desired. Tissue staining is often performed on serial sections and identifying tissue 
landmarks to locate regions of interest within MALDI samples (22) but some stains can be 
performed on sections prior to MALDI analysis and have been shown to be compatible with 
MALDI (41). 
The next step in MALDI preparation is the application of the matrix which absorbs energy 
from the laser and transfers it to the analytes in the gas phase creating a plume and promoting 
ionization (42,43). Matrix molecules ionize analytes molecules through proton transfer, often 
forming singly protonated [M+H]+ ions or multiply protonated [M+nH]n+ ions, and singly 
deprotonated [M-H]- ions. Different matrices have been developed for various analyte classes such 
as 2,5-dihydroxybenzoic acid (DHB, C7H6O4) for imaging peptides, proteins, lipids and drugs 
(37,44,45), 3,5-dimethoxy-4-hydroxycinnamic acid for proteins (SA, or sinapinic acid, C11H12O5) 
(37, 45, 46) and 1,5-diaminonaphthalene (DAN, C10H10N2) for lipids (47,48).   
Various methods have been developed for the application of matrix in liquid form, whereby a 
powdered matrix is dissolved in a solvent, or solid form to tissue sections.  In liquid form, matrix 
is applied via as aerosol spray that can be done manually (37, 49), relying on the abilities of the 
analyst, or more reliably through an automated sprayer where the matrix is applied in a repeatable 
and programmable way (50, 51).  Liquid application of matrix, while most common, presents an 
increased likelihood of large crystals forming on the surface of the sample as well as an increased 
risk of molecular delocalization (52), both of which can reduce detection and imaging quality in 
MALDI analysis.  Alternatively, sublimation is a dry approach to matrix application used to make 
uniform coatings of matrix without the limitations present in liquid approaches.  The matrix is 
heated under vacuum in a sublimation chamber while the slide is inverted and affixed to a cool 
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surface. The matrix sublimes and condenses on the cold surface of the sample, the amount 
sublimated is controlled by the temperature the matrix is heated to and time in which the heat is 
applied (53).  Sublimation also acts to remove non-volatile impurities during the sublimation and 
sample coating process (53).  After matrix application the samples are ready for MALDI analysis 
(Figure 1). 
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Figure 1. An outline of the MALDI workflow. The steps in a typical MALDI workflow consist 
of tissue sectioning and mounting on a conductive slide followed by matrix application.  The 
samples are then placed in the MALDI instrument for analysis where laser ablation occurs causing 
molecules to be ionized in a plume of matrix and analyte molecules.  An image is generated which 
can then be analyzed to obtain mass spectrometric data and molecular information. 
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1.4 Tissue Storage: Fresh Frozen vs. Formalin Fixed 
 
A critical step in the MALDI workflow is that of sample preparation when it comes to 
optimizing sensitivity and spatial resolution for the desired analytes and the type of tissue being 
tested.  Thus, preservation of sample tissue is an important factor as failure to preserve tissue in a 
timely manner may result in morphological changes and degradation of analytes within the tissue 
(54-57).  Minimizing time between tissue harvest and preservation limits the exposure of tissue 
samples to potential degradation. The main technique used to preserve samples intended for 
MALDI analysis is snap freezing where the tissue sample is exposed to a cryogen such as liquid 
nitrogen or dry ice.  Tissue, when first harvested is prone to deformation and care must be taken 
when preserving samples, a useful technique is to place tissue samples on aluminum foil and float 
it on liquid nitrogen and allowing the sample to freeze before fully wrapping the tissue in foil and 
immersing in the cryogen (24). This technique allows for slower freezing of samples compared to 
direct immersion and is useful for more delicate tissue that tends to fracture upon freezing, such 
as brain tissue.  Whole tissue samples can be stored at -80 °C without any detrimental effects on 
MALDI data for at least a year (37,58) though tissue types can vary widely, and prolonged storage 
can have differing effects. 
Long-term tissue storage however, involves fixing tissue samples in formaldehyde, 
paraformaldehyde or formalin fixatives; which are effective methods of preserving tissue 
specimens for future investigation (59).  Moreover, immersion in fixative solutions is routinely 
performed on clinical samples, such as human brain tissue, for neuropathological analysis and 
offers an alternative method of tissue storage allowing samples to be preserved at room 
temperature for an extended period of time. Through the cross-linking of proteins, fixatives act to 
disable intrinsic biomolecules and due to the toxicity of the fixative prevents extrinsic damage 
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from microorganisms. Cross-linking also helps to preserve the morphology of tissue samples by 
increasing the rigidity.  Even more so, clinical human brain samples are often sectioned in thicker 
blocks and then fixed in formalin, known as post-fixation, which can then be used in various ways, 
two of which being magnetic resonance imaging (MRI) and histological purposes.  Formalin fixed 
tissue samples can then remain stored in formalin for many years, to be kept at cool temperatures 
or can be dehydrated and embedded in paraffin, known as formalin fixed paraffin embedded 
(FFPE), for easier sectioning of small samples while allowing the tissue to remain stable for many 
years at room temperature. FFPE samples can be de-paraffinized for analysis through solvent 
washes in xylene and alcohols (60). Formalin fixation inhibits the analysis of tissue samples 
through MALDI as fixation often alters the cells within tissue, especially proteins due to protein 
cross-linking in the fixation process (61).  Formalin fixation also poses a problem for lipid imaging 
using MALDI-IMS since it has previously been thought that lipids are largely washed away during 
the fixation process (62). However, recent studies have shown that lipid ionization from fixed 
tissue samples is possible (63,64).  
Clinically, MALDI-IMS of fixed tissue has been used previously to profile lipids and proteins 
in suspected cancerous tissue (65,66) and has also been previously used to profile lipid changes in 
the brains of alcoholics (67).  High resolution imaging of formalin fixed tissue has been obtained 
in various clinical studies involving the mapping of cysteine rich proteins in skin (68) and mapping 
of extracellular proteins in human liver tissue (69). MALDI MS imaging of formalin fixed brain 
tissue has only been performed in various preclinical studies including imaging of mouse and rat 
brain sections to optimize the fixation procedure for MALDI analysis (63,70) and has yet to be 
performed on formalin fixed clinical brain samples.  Thus far MALDI MS imaging of lipids in the 
human brain has been performed solely in fresh frozen samples for studies such as examining grey 
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and white matter phospholipid distributions (71,72) as well as lipid mapping in the visual cortex 
(73) and optic nerve (74). To our knowledge high resolution imaging of certain lipid types in fixed 
human brain tissue has yet to be explored. 
1.5 The effects of tissue washing 
 
Biological samples can contain many types of molecules in varying concentrations across 
tissue types and some of the most abundant species present within tissue samples can inhibit 
detection of lesser species making them more difficult to analyze.  For example, proteins and 
peptides can be made more difficult to analyze in the presence of salts and lipids (75,76).  Problems 
that may be encountered due to the presence of other molecular species, such as poor 
crystallization, ion suppression and adduct formation can be overcome by washing the tissue 
samples prior to the application of matrix in the MALDI procedure. 
Washing protocols need to be optimized for the analyte of interest so as to remove the 
unwanted molecules while retaining the spatial distribution of analyte molecules within the tissue 
and sensitivity of the instrument for the molecule of interest.  Most commonly used is a series of 
ethanol washes for enhancing the sensitivity of proteins in MALDI analysis (37,41,77,78,79), 
though other washes such as chloroform or xylene have been used to remove lipids from tissue 
samples and improve protein detection (58). Although many washes are known to delipidate tissue 
samples, there are some washes that have been shown to enhance lipid signal detection in MALDI 
IMS (80-82). Specifically, an ammonium formate (AF) wash has been shown to effectively 
increase lipid signal to noise detected, allowing for better detection of lipids in fresh frozen rodent 
brain tissue (80,83). The wash is thought to accomplish this either by the formation of adducts or 
the removal of salt constituents from the tissue while still retaining the ability to ionize 
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biomolecules and maintaining the spatial distribution of the molecules of interest.  Currently, this 
method of lipid enhancement has not been explored for formalin fixed tissue in MALDI imaging.  
1.6 Gangliosides 
 
With many clinical samples stored in formalin, the ability to analyze lipids in MALDI IMS 
could hold potential for improving neurodegenerative disease research as lipids are essential 
molecules in the human body and are associated with many biological functions. Gangliosides, for 
example, are the most prominent lipid type within the brain accounting for 1% of lipid mass 
(84,85,86). Gangliosides are glycosphingolipids that consist of a ceramide base, which can vary in 
sphingosine chain length, attached to oligosaccharide chains that can be mono- to poly-sialylated 
(Figure 2). These molecules are critical components of both neuronal and glial lipid membranes 
within the brain and are important for many neuronal functions including cell adhesion, 
differentiation and migration, as well as synaptic transmission and myelin genesis and stability 
(87-91). 
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Figure 2. Ganglioside structure. Gangliosides contain a hydrophobic ceramide moiety that 
consists of a long-chain amino alcohol, sphingosine, which is acylated with a fatty acid on the 
amino group. The polar head is an oligosaccharide that contains a sialic acid. 
An understanding of lipid distribution throughout the brain is critical, not only due to their 
many essential functions, but also because varied levels of these molecules have been associated 
with neurodegenerative diseases. For example, reduced levels of GM1, a key brain ganglioside, 
has been linked to Huntington’s Disease, Parkinson’s Disease and Alzheimer’s disease (88,92,93); 
and is currently being investigated for its therapeutic potential (94,95,96).  On the other hand, 
simpler ganglioside species such as GM2 and GM3 have been linked to brain injury (Figure 3). 
Preclinical studies have demonstrated that ganglioside composition changes during aging such that 
complex gangliosides GM1 and GD1a are decreased while simple gangliosides such as GM2 and 
GM3 are increased (87). Additional work in the aging rat has shown that the sphingosine base 
length of gangliosides shifts from 18 carbons in length to 20 carbons in length during normal aging 
(10).  Although preclinical models are valuable to better understand the role of lipids like 
gangliosides in brain aging and disease, detection of compositional changes of gangliosides within 
human brain tissue is essential for further understanding of brain function. 
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Figure 3. Ganglioside biosynthetic and degradation pathways. Gangliosides are synthesized 
and degraded in a stepwise manner.  Synthesis, outlined by the black arrows, starts with the lipid 
precursor ceramide which is generated in the endoplasmic reticulum, and their synthesis is 
continued in the golgi complex via glycosyltransferases and sialyltransferases, adding sugar and 
sialic acid residues respectively. Ganglioside degradation, indicated by red arrows, takes place in 
the acidic compartments endosome and the lysosome, it is catalyzedcatalyzed by the glycosidases 
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and the sialidases that sequentially split off the carbohydrate and sialic acid residues (97, 98). The 
black outline indicates the most common ganglioside species found within the brain. GalNAc-T: 
Nacetylgalactosaminyltransferase or GM2/ GD2/ GT2 synthase, GalT-1: galactosyltranferase I, 
GalT-2: galactosyltranferase II or GM1 synthase, Glc-T: glucosyltransferase, Sial-T1: 
sialyltransferase I or GM3 synthase, Sial-T2: sialyltransferase II or GD3 synthase, Sial-T3: 
sialyltransferase III or GT3 synthase, Sial-T4: sialyltransferase IV or GD1a synthase, Sial-T5: 
sialyltransferase V or GT1a synthase, Gal: galactosidase, GCase: glucocerebrosidase. 
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1.7 Rationale 
 
MALDI IMS is a powerful technique able to obtain spatial information of molecules within 
biological samples directly from intact tissue sections.  The capabilities of MALDI IMS are limited 
by the types of tissue samples currently able to be analyzed, such as formalin fixed tissue samples, 
which are believed to have lipid signal suppression due to the fixation process. Therefore, a method 
of signal enhancement that would allow formalin fixed tissue to be analyzed via MALDI IMS 
would open many avenues in clinical research as many clinical samples are fixed in formalin for 
long term storage. 
Post-mortem tissue is crucial in disease research and the understanding how neurological 
diseases affect the brain. Studies have demonstrated that an aqueous wash of sectioned tissue, prior 
to matrix application, significantly enhances MALDI IMS signal. In particular, AF has been shown 
to be effective at enhancing lipid signal obtained from fresh frozen tissue sections, though it has 
not been thoroughly explored for formalin fixed tissue.  Therefore, work in this thesis aims 
establish a method of MALDI analysis of gangliosides in formalin fixed tissue utilizing an AF 
wash.  Work herein demonstrates that ganglioside imaging of formalin fixed tissue is possible 
while retaining the spatial information of gangliosides within tissue sections. This allows for 
visualization and quantification of ganglioside molecules within formalin fixed tissue samples that 
have been stored for extended periods of time, opening new avenues to further the understanding 
of how the diseased brain changes on a molecular level.   
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1.8 Aim and Hypothesis 
 
Aim: Investigate the viability of MALDI IMS in imaging gangliosides retained in formalin 
fixed tissue that has been stored for long periods of time utilizing an AF wash to enhance the signal 
from the tissue. 
 
Hypothesis: Imaging of gangliosides from formalin fixed clinical tissue samples will be 
possible by improving ganglioside detection in negative ion mode MALDI IMS. 
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Chapter 2: Methods  
 
2.1 Chemicals 
 
Ammonium Hydroxide, Formic Acid, and 1,5-Diaminonapthalene (DAN, Sigma-Aldrich, 
Oakville, ON, Canada). A buffer solution of Ammonium Formate was prepared from 0.05 M 
solutions of ammonium hydroxide and formic acid in equal amounts to create a 0.05 M AF 
solution. 
2.2 Brain tissue sample preparation 
 
All animal protocols were approved by the Canadian Council on Animal Care and Western 
University Animal Care Committee (2016-027). Rat brains were isolated from 3-month old male 
Wistar rats.  Rat brains were flash-frozen in dry ice immediately after dissection, sections of these 
brains were used as “fresh frozen tissues” (n=5) and sections were immersed in formalin post 
sectioning to be used as “post-fixed tissues” (n=5).  Fresh frozen tissue was stored at - 80° C until 
use.  Tissue blocks were obtained from the cerebral cortex of post-mortem human brains (n=5) 
containing both grey and white matter with the help of a neuropathologist. Non-identified human 
pathological specimens from post-fixed brains were stored in 10% formalin for variable lengths of 
time (from 5 to 15 years).  Human post-fixed brain tissue was maintained in formalin and stored 
at -4° C until use. 
 Brain samples were sectioned using a cryostat (Thermo-Fisher Scientific CryoStar NX50, 
Toronto, Canada) at a thickness of 10 μm and thaw mounted onto glass slides, 75 mm by 25 mm, 
coated with electrically conductive Indium-Tin-Oxide (ITO) (Hudson Surface Technology Inc., 
Old Tappan, NY, USA).  Rat brain sections to be post-fixed were subsequently immersed in 10% 
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formalin for 15 minutes, then allowed to dry for 5 minutes open to the air and another 10 minutes 
in a desiccator under vacuum. Sections of rat brain were taken from the area depicted in Figure 4 
and sections of human tissue were taken from the brain area depicted in Figure 
AF solution was kept at a pH of 6.4 and a temperature of 4° C, the AF wash was performed 
by submerging the desired tissue sections mounted on glass slides in the 0.05 M AF solution for 
30 seconds, the slides were then allowed to dry for 5 minutes open to the air and 10 minutes in a 
desiccator under vacuum as previously described (80). 
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Figure 4. Location of rat brain tissue sections used in experiments. Rat brain atlas depicting 
brain region that fresh frozen and post fixed rat brain sections were obtained from (99). 
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2.3 MALDI-IMS 
 
Slides mounted with rat brain tissue sections were coated with a thin layer of 1,5-
Diaminonapthalene (DAN, Sigma-Aldrich, Oakville, ON, Canada) matrix via sublimation for 8 
minutes at 140 °C. The slides were incubated at −20 °C overnight prior to MALDI IMS.  The 
assembly of the apparatus and sublimation of matrix was performed as previously described (48).  
Mass Spectrometry data were obtained using a Sciex 5800 MALDI TOF/TOF MS 
instrument (Framingham, MA, USA). Data acquisition and data processing were respectively done 
using a TOF/TOF Series Explorer and Data Explorer software (Sciex). The instrument is equipped 
with a 349 nm Nd:YLF OptiBeam On-Axis laser and set to a laser pulse rate of 400 Hz. Reflectron 
negative mode was used and was externally calibrated at 50 ppm mass tolerance and internally at 
10 ppm. Image acquisition was performed in reflectron negative ion mode, with an 80 μm laser 
step distance. A mass spectrum with a 1000–2000 m/z range was acquired for each laser shot. 
2.4 Processing of Molecular Image Data and Data Analysis 
 
MS imaging data were visualized using TissueView software (Sciex). All images were 
optimized for visual expression, the color intensities do not show the same signal intensity across 
different images. Independent t-tests were performed on each pair of control and wash tissue to 
test for significant increase in signal intensity. Molecular identities were determined using 
LipidMAPS with further identification of ganglioside species through tandem mass spectrometry 
(MS/MS) (Figure 8). 
MS data exported from TissueView was analyzed in Prism 7 software. Area under curve 
(AUC) analysis was generated for each peak of interest, obtaining an area ratio of individual peak 
area to area under the entire spectrum. Fold increase values for each peak were obtained by 
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comparing washed AUC values/Control AUC values.  Values shown in figures and tables are 
averaged from all trials of the respective tissue types, n=5 for each tissue type. 
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Chapter 3: Results 
 
3.1 Enhanced GM1 detection following AF wash in fresh frozen rat brain 
 
To evaluate the effectiveness of the AF wash, MALDI-IMS was first performed on 
adjacent sections of fresh frozen coronal rat brain tissue sections to observe the difference in spatial 
distribution both d18:1 and d20:1 species of GM1 within the striatum (Figure 5A).  The spatial 
distribution of d18:1 GM1 molecules in tissue was preserved following the AF wash while 
demonstrating an increase in signal intensity throughout the intensity map image. Similar effects 
were observed for the less abundant d20:1 species of GM1.  The mass spectra of the striatum 
region (dotted circle in Figure 5A) obtained showed a significant increase in signal for the total 
spectrum of AF washed tissue (Figure 5B) as well as for the individual GM1 peaks (Figure 5B) 
while maintaining a similar signal to noise ratio as the unwashed tissue. To assess the effectiveness 
of the wash, the signals for AF washed and control unwashed tissues were quantified. A 
comparative analysis was then performed which showed an almost 3-fold increase (Figure 5D, 
p<0.05) in GM1 d20:1 signal as a result of washing with AF.  Similar increases in ganglioside 
signal were observed in white matter specific regions, such as the corpus callosum (Red Dot in 
Figure 5A, Figure 5E-F), and grey matter specific regions, such as the cerebral cortex (Blue Dot 
in Figure 5A, Figure 5H-J). To further asses the AF wash, other ganglioside signals appearing in 
Figure 5B were quantified and are outlined in Table 1.  
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Figure 5. The effect of AF wash on the MALDI-IMS signals of gangliosides in fresh frozen 
rat brain tissue. A comparison of ganglioside GM1 detection in the white and grey matter areas 
of fresh frozen rat brain tissue from control and AF washed samples.  Signal enhancement is 
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observed from the mass spectra and degree of signal enhancement can be seen through a 
comparative area under curve analysis of GM1.  (A) MALDI-IMS generated intensity maps of 
GM1 d18:1 and d20:1 from control and AF washed fresh frozen rat brain tissue. Striatum, corpus 
callosum and cortex regions of the brain labelled with a dotted white circle, a red dot and blue dot 
respectively.  (B) Mass spectra of gangliosides and other lipids from the striatum (dotted circles in 
A). (C) Mass spectra of GM1 d18:1 and d20:1 from the striatum (D) Quantification of GM1 d18:1 
and d20:1 species in the striatum. (E) Mass spectra of gangliosides and other lipids from the corpus 
callosum. (F) Mass spectra of GM1 d18:1 and d20:1 from the corpus callosum (G) Quantification 
of GM1 d18:1 and d20:1 species in the corpus callosum. (H) Mass spectra of gangliosides and 
other lipids from the cerebral cortex. (I) Mass spectra of GM1 d18:1 and d20:1 from the cerebral 
cortex. (J) Quantification of GM1 d18:1 and d20:1 species in the cerebral cortex.  * indicates 
statistical significance, Student’s t-test, p<0.05, n=5 for each experimental group. 
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Table 1. The effect of AF wash on the MALDI-IMS signals of gangliosides in fresh frozen rat 
brain tissue. Ratio of signal enhancement (RSE) and standard error mean (SEM) from the 
striatum, corpus callosum and cerebral cortex regions of fresh frozen rat brain tissue sections due 
to washing with ammonium formate. *GT3 C20 showed an abnormally high enhancement ratio 
due to its minimal presence in unwashed samples, thus the ratio observed may not be representative 
of the actual signal enhancement. 
 
 
Molecular 
Identity 
m/z RSE 
Striatum 
SEM 
Striatum 
RSE 
Corpus 
Callosum 
SEM 
Corpus 
Callosum 
RSE 
Cerebral  
Cortex 
SEM 
Cerebral 
Cortex 
GM3 C18 1180.4 1.0 0.11 1.3 0.09 0.8 0.07 
GM2 C18 1383.5 1.0 0.11 0.9 0.07 0.8 0.12 
GM2 C20 1411.6 1.2 0.29 0.8 0.04 0.8 0.11 
GD3 C18 (K+) 1511.6 2.4 0.31 1.3 0.10 1.8 0.34 
GM1 C18 1545.7 2.2 0.33 2.5 0.75 2.8 0.33 
GM1 C20 1573.7 2.9 0.49 2.2 0.50 3.1 0.55 
GD2 C16 (K+) 1686.0 1.9 0.30 n/a n/a 1.4 0.33 
GD2 C18 (K+) 1715.7 1.7 0.66 n/a n/a 1.9 0.98 
GT3 C20 1792.8 14.9* 5.96 2.6 0.38 14.7 8.70 
GT3 C22 1820.9 7.8 2.49 1.6 0.31 7.1 3.68 
GD1 C18 1837.2 2.9 0.35 1.4 0.28 3.1 0.44 
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3.2 MALDI-IMS of gangliosides in formalin fixed tissue 
 
 We next aimed to assess the effects of the aqueous wash on post-fixed rat brain tissue 
sections, a similar fixation method to the storage of human tissue used for clinical studies.   
MALDI-IMS images obtained from formalin post-fixed rat brain tissue sections, with and without 
AF wash, showed the expected signal intensity enhancement and similar spatial resolutions. The 
spectra obtained from formalin post-fixed tissue was similar to those obtained from fresh frozen 
tissue, showing an increase in lipid signal while retaining a low signal to noise ratio (Figure 6B).  
The mass spectra of the striatum region (dotted circle in Figure 6A) obtained showed a significant 
increase in signal for the total spectrum of AF washed tissue (Figure 6B) as well as for the 
individual GM1 peaks (Figure 6C) while maintaining a similar signal to noise ratio as the 
unwashed tissue.  Quantification of GM1 species show a statistically significant increase in both 
d18:1 and d20:1 species in the AF washed rat brain tissue sections (p<0.05, Figure 6D). As with 
the fresh frozen rat tissue samples, similar increases in ganglioside signal were observed in white 
matter specific regions, such as the corpus callosum (Red Dot in Figure 6A, Figure 6E-F), and 
grey matter specific regions, such as the cerebral cortex (Blue Dot in Figure 6A, Figure 6H-J). The 
changes in signal intensities for other gangliosides appearing within the spectrum are outlined in 
Table 2. 
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Figure 6. The effect of AF wash on the MALDI-IMS signals of gangliosides in formalin post-
fixed rat brain tissue. A comparison of ganglioside GM1 detection in the white and grey matter 
areas of post-fixed rat brain tissue from control and AF washed samples.  Signal enhancement is 
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observed from the mass spectra and degree of signal enhancement can be seen through a 
comparative area under curve analysis of GM1.  (A) MALDI-IMS generated intensity maps of 
GM1 d18:1 and d20:1 from control and AF washed formalin post-fixed rat brain tissue. Striatum, 
corpus callosum and cortex regions of the brain labelled with a dotted white circle, a red dot and 
blue dot respectively.  (B) Mass spectra of gangliosides and other lipids from the striatum (dotted 
circles in A). (C) Mass spectra of GM1 d18:1 and d20:1 from the striatum (D) Quantification of 
GM1 d18:1 and d20:1 species in the striatum. (E) Mass spectra of gangliosides and other lipids 
from the corpus callosum. (F) Mass spectra of GM1 d18:1 and d20:1 from the corpus callosum 
(G) Quantification of GM1 d18:1 and d20:1 species in the corpus callosum. (H) Mass spectra of 
gangliosides and other lipids from the cerebral cortex. (I) Mass spectra of GM1 d18:1 and d20:1 
from the cerebral cortex. (J) Quantification of GM1 d18:1 and d20:1 species in the cerebral cortex.  
* indicates statistical significance, Student’s t-test, p<0.05, n=5 for each experimental group. 
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Table 2. The effect of AF wash on the MALDI-IMS signals of gangliosides in formalin post-
fixed rat brain tissue. Ratio of signal enhancement (RSE) and standard error mean (SEM) from 
the striatum, corpus callosum and cerebral cortex regions of post-fixed rat brain tissue sections 
obtained from an area under curve comparison of control to AF washed tissue. 
 
 
 
Molecular 
Identity 
m/z RSE 
Striatum 
SEM 
Striatum 
RSE 
Corpus 
Callosum 
SEM 
Corpus 
Callosum 
RSE 
Cerebral 
Cortex 
SEM 
Cerebral 
Cortex 
GM3 C18 1180.4 1.2 0.09 1.2 0.19 1.1 0.16 
GM2 C18 1383.5 1.0 0.04 1.2 0.39 0.8 0.07 
GM2 C20 1411.6 1.0 0.08 0.8 0.12 0.8 0.10 
GD3 C18 (K+) 1511.6 2.0 0.17 2.1 0.23 1.3 0.09 
GM1 C18 1545.7 1.5 0.19 1.9 0.67 1.6 0.39 
GM1 C20 1573.7 2.0 0.33 1.6 0.41 1.9 0.49 
GD2 C16 (K+) 1686.0 1.6 0.16 1.0 0.15 1.1 0.16 
GD2 C18 (K+) 1715.7 0.9 0.10 0.8 0.13 0.9 0.10 
GT3 C20 1792.8 4.0 0.73 2.3 0.49 3.7 1.42 
GT3 C22 1820.9 3.5 0.62 2.2 0.51 3.7 1.20 
GD1 C18 1837.2 2.9 0.53 1.7 0.29 2.7 0.43 
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3.3 MALDI-IMS of formalin post-fixed human brain tissue 
 
 We next aimed to assess the potential for the AF wash to enhance MALDI-IMS signal in 
human brain tissue that had been post-fixed in formalin and stored in formalin for various lengths 
of time, up to 15 years (Figure 7).  Cerebral cortex comprising both white matter and grey matter 
was chosen and MALDI-IMS images were acquired from control and AF washed tissue (Figure 
7A).  AF washed human brain tissue showed a greater overall signal in the mass spectrum in both 
the grey matter (Figure 7B) and white matter (Figure 7E) of the cerebral cortex. The cortical white 
matter in human tissue contained significantly more lipid molecules than the grey matter of the 
brain, however GM1 was significantly more abundant the grey matter.  AF wash significantly 
increased GM1 signal in both grey matter (Figure 7C) and white matter (Figure 7F). Quantification 
of GM1 signals revealed a significant increase in d18:1 and d20:1 signal in the grey matter (Figure 
7D) and significant increase in d18:1 signal in the white matter (Figure 7G) of AF washed tissue 
compared to controls (p<0.05). Signal enhancement of other prominent gangliosides is shown in 
Table 3. Confirmation of GM1 d:18 and d:20 molecular identity was obtained through the use of 
MS/MS comparing the characteristic peaks obtained from rat and human samples to ensure that 
the same molecule was being detected in each case. (Figure 8). 
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Figure 7. The effect of AF wash on the MALDI-IMS signals of gangliosides in formalin post-
fixed human brain tissue. A comparison of ganglioside GM1 detection in the white and grey 
matter areas of fixed human brain tissue from control and AF washed samples.  Signal 
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enhancement is observed from the mass spectra and degree of signal enhancement can be seen 
through a comparative area under curve analysis of GM1. (A) MALDI-IMS generated intensity 
maps of GM1 d18:1 and d20:1 from control and AF washed formalin post-fixed human cerebral 
cortical brain tissue. Mass spectra of gangliosides and other lipids from the human cerebral cortical 
(B) grey matter and (E) white matter (outlined in A: GM-grey matter; WM-white matter). Mass 
spectra of GM1 d18:1 and d20:1 from the cortical (C) grey matter and (F) white matter.  (D) 
Quantification of GM1 d18:1 and d20:1 species in cortical grey matter and (G) white matter * 
indicates statistical significance, Student’s t-test, p<0.05, n=5 for each experimental group. (H) 
Hematoxylin and eosin stain of tissue block visualized in A & B. (I) Area tissue blocks were taken 
from human brain tissue. (J) Atlas image of associated brain region of tissue blocks depicting 
anatomical landmarks present in sections (100). 
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Table 3. The effect of AF wash on the MALDI-IMS signals of gangliosides in formalin fixed 
human brain tissue. Ratio of signal enhancement (RSE) and standard error mean (SEM) from the 
cortical grey matter of formalin fixed human brain tissue sections obtained from an area under 
curve comparison of control to AF washed samples. 
 
 
 
 
Molecular Identity 
(Grey Matter) 
m/z RSE SEM 
 
GM3 C18 1180.4 1.0 0.19 
GM2 C18 1383.5 1.3 0.12 
GM2 C20 1411.6 1.3 0.16 
GM1 C18 1545.7 1.9 0.12 
GM1 C20 1573.7 1.9 0.15 
GM1 C22 1601.8 2.2 0.46 
    
Molecular Identity 
(White Matter) 
m/z RSE SEM 
 
GM1 C18 1545.7 2.0 0.36 
GM1 C20 1573.7 2.8 1.2 
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Figure 8. On-tissue negative mode MS/MS identification of the major ganglioside species. 
Comparison of ganglioside species detected from rat and human samples confirms that the same 
ganglioside species are being detected in each case. A. GM1 d18:1 (m/z 1545) obtained from rat 
brain tissue; B. GM1 d18:1 (m/z 1545) obtained from human brain tissue C. GM1 d20:1 (m/z 
1573) obtained from rat brain tissue; D. GM1 d20:1 (m/z 1573) obtained from human brain tissue. 
MS/MS spectra produced the diagnostic fragmentation ions which corresponded to the data 
previously reported [41]. Generally, fragmentation confirmed that sialic acid produced an intense 
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peak at m/z 290 with additional characteristic fragmentation of various sugar units (m/z 564, 727, 
and/or 888). Characterization of gangliosides was performed on-tissue using a SCIEX 5800 
MALDI TOF-TOF mass spectrometer. DAN matrix was applied onto tissue sections by 
sublimation and negative ion MS/MS spectra were acquired. The detector multiplier voltage was 
maximized at 2.25 kV and a total of 900 shots per spectrum was acquired in a continuous stage 
motion. Following the external calibration at ± 50 ppm mass tolerance, the precursor ion was 
isolated within an m/z window of 40 full width at half maximum (FWHM) resolution and 
fragmented in a posts-source decay mechanism. MS/MS mode experiments were conducted using 
10 to 20 % higher laser energy compared to the MS mode, in order to promote fragmentation of 
the analytes of interest for structural identification. 
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3.4 Comparison of Fresh Frozen and Formalin Fixed MALDI-IMS 
 
 Following the assessment of the AF wash on each tissue type, a side by side comparison 
of fresh frozen and formalin fixed tissues is shown in Table 4 showing the ratio of signal 
enhancement of the prominent gangliosides detected in each tissue type. Focusing on GM1 as the 
example, fresh frozen tissue is observed to have a higher degree of signal enhancement following 
an AF wash compared to formalin fixed tissue in both rat and human.  When comparing formalin 
fixed samples of rat and human brain samples, both show similar degrees of signal enhancement 
of a 2-fold increase. 
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Table 4. Side by side comparison of degree of signal enhancement from all types of tissue 
tested. Ratio of signal enhancement (RSE) from fresh frozen and post-fixed rat brain tissue and 
from post-fixed human tissue obtained from an area under curve comparison of control to AF 
washed samples. 
 
 
 
 
Molecular 
Identity 
 
 
m/z 
RSE 
(Fixed Human 
Grey Matter) 
RSE 
(Fixed Rat 
Grey Matter) 
RSE 
(Fresh Frozen Rat 
Grey Matter) 
GM3 C18 1180.4 1.0 1.1 0.8 
GM2 C18 1383.5 1.3 0.8 0.8 
GM2 C20 1411.6 1.3 0.8 0.8 
GM1 C18 1545.7 1.9 1.6 2.8 
GM1 C20 1573.7 1.9 1.9 3.1 
     
 
Molecular 
Identity 
 
 
m/z 
RSE 
(Fixed Human 
White Matter) 
RSE 
(Fixed Rat 
White Matter) 
RSE 
(Fresh Frozen Rat 
White Matter) 
GM1 C18 1545.7 2.0 1.9 2.5 
GM1 C20 1573.7 2.8 1.6 2.2 
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Chapter 4: Discussion 
  
The main objective of this study was to establish a method of detecting and imaging 
gangliosides from formalin fixed tissue in negative ion mode MALDI IMS, for the clinical 
applicability and reproducibility of formalin fixed tissue imaging.  This was accomplished utilizing 
an aqueous wash of AF, previously shown to increase signal in MALDI IMS (80,83). To our 
knowledge, this is the first time that gangliosides have been visualized in formalin fixed clinical 
brain samples utilizing MALDI-IMS. The intensity maps generated for d18:1 and d20:1 species of 
ganglioside GM1 show a significant increase in signal on all tissues tested while retaining the 
spatial distribution of the molecules within the tissue section.  This demonstrates that an aqueous 
wash with AF is a method of signal enhancement applicable to multiple types of tissue analyzed 
by MALDI-IMS.   
 Spectra generated from the analyzed tissue sections further demonstrated the ability of the 
AF wash to enhance ganglioside signals within tissue sections. The spectra were focused to the 
GM1 species present in the tissue to compare pre and post washed sections for further evaluation 
and a comparative analysis showed a 3-fold increase for fresh frozen tissue and an approximately 
2-fold increase for post-fixed tissue samples. Results indicate that immersion in formalin does 
have a detrimental effect on the amount of lipids that remain in tissue post-fixation as the fresh 
frozen and post-fixed brain sections were obtained from the same animal but the degree of signal 
enhancement was a not as high in fixed tissue as it was in the frozen tissue. However, upon 
comparison of signal from formalin fixed rat brain samples that had been post-fixed in formalin 
for 15 minutes and human brain tissue samples that had remained in formalin up to 15 years, a 
similar degree of signal enhancement is observed, indicating that the length of time tissue samples 
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are immersed in formalin may not affect the lipids within the samples to the extent that was 
previously believed. 
 MALDI IMS, although an effective technique, is not without its limitations. One of the 
limitations is that each mass spectrum obtained from individual images is unique in signal intensity 
and signal to noise ratio based on minute differences in the sample preparation, matrix application, 
variations within the tissue itself and various other inevitable variables (101). In the present work, 
these variables were accounted for by performing experiments of washed and control tissue at the 
same time and under the same conditions for a comparative analysis rather than absolute 
quantification, removing sample-to-sample variation as much as possible. An additional limitation 
of GM1 quantification using MALDI IMS is the potential of sialic acid loss from polysialated 
ganglioside species such as GD1 and GT3, also detected in the present experiment, which can 
increase the observed signal of monosialylated GM1 (102). 
 The results of this study give way to many avenues for future research.  Previous research 
that has only looked at profiled various lipids and other molecules within formalin fixed tissue up 
to this point can be expanded upon.  For example, the study performed by de la Monte et. al. (67) 
profiled many lipids, including sphingolipids such as gangliosides, in the white matter of human 
alcoholics to assess the lipid changes associated with alcoholism.  Utilizing an aqueous wash 
method, brain sections from alcoholics and non-alcoholics could be imaged and the spatial 
distribution of the lipids examined, providing more information on the distribution of these 
changes throughout the brain and with higher sensitivity.  The same is true for studies that have 
studied formalin fixed cancerous tissue through lipid profiling (65,66).  By examining clinical 
sections of cancerous tumors and surrounding tissue, a deeper understanding of the lipid changes 
occurring as a result of tumor growth could be obtained.  It is also possible that lipids previously 
43 
 
in too low of a quantity to be detected could be detected in clinical tissue through the use of an 
aqueous wash, further expanding changes observed within these studies. 
 Imaging of formalin fixed brain tissue in particular will allow for further studies of clinical 
brain samples diagnosed with a neurodegenerative disease that have been kept in storage for 
extended periods of time.  One such avenue is in tissue diagnosed with Alzheimer’s disease, both 
early and late stage diseased samples.  An indicator of Alzheimer’s disease is the appearance of 
brain lesions as white, hyperintense areas within MRI images of the brain, also known as white 
matter hyperintensities.  By locating the areas with white matter hyperintensities in clinical 
samples and blocking them for sectioning, it would allow for the study the changes occurring 
within these lesions compared to normal appearing white matter in the MRI.  If molecular changes 
can be identified specific to the hyperintense regions, it could give direction to possible therapeutic 
pre-treatment methods for Alzheimer’s disease. 
 Although ganglioside GM1 was selected for the focus of these studies to show imaging of  
lipids is possible in formalin fixed clinical brain tissue, exploring the potential of imaging other 
lipids, proteins or peptides in fixed tissue utilizing an aqueous wash is an avenue that should be 
explored.  Imaging of proteins has been performed in pre-clinical tissue (68,69) but to our 
knowledge has yet to be performed in clinical brain tissue.  It may be possible to image some 
proteins after fixation if their signal can be enhanced which could offer more avenues for study.  
This also prompts the study of other aqueous buffers to be tested for the possibility that they pay 
have preferential interactions with specific molecules allowing for the detection and study of those 
molecules in MALDI IMS. 
 Lastly, though the exact mechanism of enhancement caused by the aqueous wash is 
unknown, it does appear to be independent of the matrix used for MALDI analysis as DAN was 
44 
 
used in these studies and DHB has been utilized in literature (80) with tissue washed with an 
aqueous buffer.  Studies have also examined the effectiveness of molecular signal enhancement 
via an aqueous wash in ESI (83), but as of yet an ESI has not used this method for imaging formalin 
fixed brain tissue.  A comparative study of fixed clinical tissue between MALDI and ESI would 
determine the consistency of the wash method across multiple platforms and possible show 
differing molecules based on the method of molecular ionization. 
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Conclusions 
 
 In summary, MALDI IMS is a viable and effective method of analyzing gangliosides from 
formalin fixed tissue samples through the use of an ammonium formate wash to enhance the signal 
from obtained from the tissue samples.  When compared to control tissue, an AF wash yields a 2- 
to 3-fold increase in overall spectra signal while retaining a relatively low signal to noise ratio and 
maintaining spatial distribution of molecules within the samples.  Visualization of analyte 
molecules was qualitatively improved in the AF washed images compared to the control images.  
These results are promising for future analysis and visualization of formalin fixed clinical samples, 
as well as for the future understanding of neurodegenerative diseases utilizing MALDI-IMS. 
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